4Krogsgaard LR, Engsbro AL, Bytzer P. The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults 50 years of age. ScandJ Gastroenterol, 2013, 48(5): 523-529.
5Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel syndrome. Br Med J, 1978, 2(6138): 653-654.
6Saito YA, Locke GR, Talley NI, et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol, 2000, 95(10): 2816-2824.
7Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut, 1999, 45(2): 1143-1147.
8Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology, 2006, 130(5): 1377-1390.
9Levy C, Charbonnier A, Cachin M. Pinaverium bromide and functional disease (double blind study). Sere Hop Ther, 1977, 53(7- 8): 372-374.
10Delmont J. lnteretdel'adonctiond'un antispasmodique musculotrope autraitement des constipations douloureuses des colopathies fonctionnelles par le son. Med Chir Dig, 1981, 4(43): 365-370.
